Home › NDC Lookup › RxCUI directory › RxCUI 2266530

Infliximab-axxq 100 MG Injection [Avsola] — RxCUI 2266530

Name: Infliximab-axxq 100 MG Injection [Avsola] (RxCUI 2266530)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2266530 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2266530

Official nameInfliximab-axxq 100 MG Injection [Avsola]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAvsola 100 MG Injection

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)10,846 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Infliximab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats inflammatory conditions including Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. Which one a...
You get it as a slow IV infusion lasting at least 2 hours at a medical setting. You'll usually have the first few doses at weeks 0, 2 and 6, then regular doses after that. Your car...
Common ones are colds and sinus infections, headache, stomach pain and reactions during the infusion such as flushing, rash or shortness of breath. You may get pre-medicines to hel...
Call right away for fever, chills, a cough that won't go away or other signs of infection. Also call for yellow skin or eyes, new heart failure symptoms, unusual bleeding or bruisi...

📖 Read our full Infliximab Injection guide →

🕸️ Concept Web — How Infliximab-axxq 100 MG Injection [Avsola] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Infliximab-axxq 100 MG Injection [Avsola] RxCUI 2266530 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Infliximab 191831 IN
- Infliximab-axxq 2266523 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Avsola 2266526 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Infliximab Injection 1655941 SCDF
- Infliximab-axxq Injection 2647761 SCDFP
- Infliximab Injectable Product 1160692 SCDG
- Infliximab-axxq Injectable Product 2662687 SCDGP
- Infliximab Injection [Avsola] 2266528 SBDF
- Infliximab-axxq Injection [Avsola] 2654700 SBDFP
- Avsola Injectable Product 2266529 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Infliximab-axxq 100 MG Injection 2266525 SCD
- Infliximab-axxq 100 MG 2266524 SCDC
- Infliximab-axxq 100 MG [Avsola] 2266527 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Infliximab-axxq 100 MG Injection SCD · 2266525
Infliximab-axxq 100 MG SCDC · 2266524
Infliximab Injection SCDF · 1655941
Infliximab-axxq Injection SCDFP · 2647761
Infliximab Injectable Product SCDG · 1160692
Infliximab-axxq Injectable Product SCDGP · 2662687

Brand-Name Concepts

Infliximab-axxq 100 MG [Avsola] SBDC · 2266527
Infliximab Injection [Avsola] SBDF · 2266528
Infliximab-axxq Injection [Avsola] SBDFP · 2654700
Avsola Injectable Product SBDG · 2266529
Avsola BN · 2266526

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2266530 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55513-0670-01	1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-01) / 10 mL in 1...	AVSOLA	Amgen, Inc	2019-12-12
55513-0670-21	1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-21) / 10 mL in 1...	AVSOLA	Amgen, Inc	2025-09-01

Observed labelers: Amgen, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5121	Inj. avsola, 10 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.